Background COVID-19 is an infectious disease characterized by multiple respiratory and
extrapulmonary manifestations, including gastrointestinal symptoms. Although recent …

Objective Although COVID-19 is primarily a respiratory illness, there is mounting evidence
suggesting that the GI tract is involved in this disease. We investigated whether the gut …

Emerging evidence indicates that the gut microbiome contributes to the host immune
response to infectious diseases. Here, to explore the role of the gut microbiome in the host …

COVID-19 is an acute respiratory distress syndrome and is often accompanied by
gastrointestinal symptoms. The SARS-CoV-2 has been traced not only in nasopharyngeal …

COVID-19 is mainly associated with respiratory distress syndrome, but a subset of patients
often present gastrointestinal (GI) symptoms. Imbalances of gut microbiota have been …

Since the outset of the coronavirus disease 2019 (COVID-19) pandemic, the gut microbiome
in COVID-19 has garnered substantial interest, given its significant roles in human health …

Background & Aims We investigate interrelationships between gut microbes, metabolites,
and cytokines that characterize COVID-19 and its complications, and we validate the results …

The gastrointestinal tract is involved in coronavirus disease 2019 (COVID-19) caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The gut microbiota has …

Gut microbiome alterations may play a paramount role in determining the clinical outcome of
clinical COVID-19 with underlying comorbid conditions like T2D, cardiovascular disorders …

The microbial populations in the gut microbiome have recently been associated with COVID-
19 disease severity. However, a causal impact of the gut microbiome on COVID-19 patient …